Skip to main content
SpringerLink
Log in

Poor control of severe asthma − controller meds drive costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Nordon C, et al. Clinical and economic burden of severe asthma: A French cohort study. Respiratory Medicine 144: 42-49, Nov 2018. Available from: URL: http://dx.doi.org/10.1016/j.rmed.2018.10.002

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poor control of severe asthma − controller meds drive costs. PharmacoEcon Outcomes News 816, 25 (2018). https://doi.org/10.1007/s40274-018-5445-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5445-6

Search

Navigation